General

Scientists closer to identify Parkinson’s biomarkers

Scientists at University of Galway have identified a set of biomarkers which can distinguish patients with Parkinson’s disease from those not affected.

Enzyme-linked,Immunosorbent,Assay,(elisa),,Immunology,Testing,Method,In,96,Wells
Enzyme-linked immunosorbent assay (ELISA), Immunology testing method in 96 wells microplate

Scientists at University of Galway have identified a set of biomarkers which can distinguish patients with Parkinson’s disease from those not affected.

The study, published in the journal Molecular Neurobiology, provides a new direction for research towards a blood-based test, which combined with the current approach of clinical and neuropsychological testing would improve the diagnosis of Parkinson’s disease.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free